The NRAS gene is a well know oncogene in cancer that encodes for a GTP binding intracellular protein that interacts with the EGFR receptor and in 2018 has proposed as a possible biomarker for advanced prostate cancer [68]. The gene discussed is NRAS; the disease is prostate carcinoma.